Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes (Q33521011)

27 July 2017

Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes (English)

1 reference

27 July 2017

0 references

0 references

0 references

pulmonary tuberculosis

1 reference

1 reference

7

Reinout van Crevel

0 references

Bachti Alisjahbana

5

object named as

Bachti Alisjahbana

1 reference

27 July 2017

1

Rovina Ruslami

1 reference

27 July 2017

Hanneke M J Nijland

2

1 reference

27 July 2017

I Gusti N Adhiarta

3

1 reference

27 July 2017

Sri H K S Kariadi

4

1 reference

27 July 2017

Rob E Aarnoutse

6

1 reference

27 July 2017

language of work or name

English

0 references

publication date

28 December 2009

1 reference

Antimicrobial Agents and Chemotherapy

27 July 2017

1 reference

27 July 2017

54

1 reference

27 July 2017

1068-1074

1 reference

27 July 2017

3

1 reference

A step-wise approach to find a valid and feasible method to detect non-adherence to tuberculosis drugs.

27 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Pharmacokinetics of ethambutol in children and adults with tuberculosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Bioavailability of rifampicin in Indonesian subjects: a comparison of different local drug manufacturers.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Pharmacokinetic interactions with rifampicin : clinical relevance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Therapeutic drug monitoring in the treatment of tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Pharmacokinetic drug interactions with rifampicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2825975

Non-linear pharmacokinetics of rifampicin in healthy Asian Indian volunteers

31 October 2018

1 reference

12 December 2020

Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion

1 reference

12 December 2020

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

12 December 2020

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

12 December 2020

Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients

1 reference

12 December 2020

Diabetes mellitus and pulmonary tuberculosis

1 reference

12 December 2020

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

1 reference

12 December 2020

Pharmacokinetics of rifampicin

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00447-09

1 reference

27 July 2017

1 reference

27 July 2017

1 reference